2121. In vitro Synergy of the Combination of Sulbactam-Durlobactam and Cefepime at Clinically Relevant Concentrations Against A. baumannii, P. aeruginosa, and Enterobacterales

BACKGROUND: Due to the incidence of polymicrobial nosocomial infections, effective therapies with activity against Acinetobacter baumannii (ACB), P. aeruginosa (PSA) and Enterobacterales are needed. Sulbactam-durlobactam (SUL-DUR) has potent, selective activity against ACB. Cefepime (FEP) is a commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouad, Aliaa, Nicolau, David P, Gill, Christian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678025/
http://dx.doi.org/10.1093/ofid/ofad500.1744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678025/
http://dx.doi.org/10.1093/ofid/ofad500.1744

Ejemplares similares